Trieu Vuong bought OTLC

January 29, 2025 · Form 4 insider transaction

Trieu Vuong bought 183,066 shares of Oncotelic Therapeutics, Inc. at $0.03 per share, a transaction worth $5.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.